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Lianfeng Zhang and Chuan Qin*Abstract
Background: The current study was conducted to establish animal models (including mouse and ferret) for the
novel avian-origin H7N9 influenza virus.
Findings: A/Anhui/1/2013 (H7N9) virus was administered by intranasal instillation to groups of mice and ferrets,
and animals developed typical clinical signs including body weight loss (mice and ferrets), ruffled fur (mice),
sneezing (ferrets), and death (mice). Peak virus shedding from respiratory tract was observed on 2 days post
inoculation (d.p.i.) for mice and 3–5 d.p.i. for ferrets. Virus could also be detected in brain, liver, spleen, kidney, and
intestine from inoculated mice, and in heart, liver, and olfactory bulb from inoculated ferrets. The inoculation of
H7N9 could elicit seroconversion titers up to 1280 in ferrets and 160 in mice. Leukopenia, significantly reduced
lymphocytes but increased neutrophils were also observed in mouse and ferret models.
Conclusions: The mouse and ferret model enables detailed studies of the pathogenesis of this illness and lay the
foundation for drug or vaccine evaluation.
Keywords: H7N9, Animal model, BALB/c mouse, FerretIn March 2013, a novel avian-origin H7N9 subtype in-
fluenza virus was recognized as the causative agent of
influenza-like illnesses in humans in Eastern China [1].
Most patients presented with respiratory infections that
progressed to severe pneumonia and dyspnea [1]. By
August 6, there are 132 human infections, with 43 fatal,
identified in 10 provinces on mainland of China, and one
imported case was also found in Taiwan. It is an urgency
to establish animal models for this virus to evaluate drug
or vaccines, and lay the foundation for further pathogenic
mechanism research. In this study, BALB/c mouse and
ferret (Mustela putorius furo) models were chosen for ani-
mal model establishment for H7N9 virus.
Mice do not run fevers or develop easy-to-measure re-
spiratory clinical signs post inoculated with influenza vi-
ruses, however, mice display numerous physical signs of* Correspondence: qinchuan@pumc.edu.cn
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reproduction in any medium, provided the orillness (including mortality, weight loss, ruffled fur, and
lethargy) that can be used as indicator of pathogenicity.
Female 6-week-old specific pathogen-free BALB/c mice
used in this study were obtained from the Institute of
Laboratory Animal Sciences, Beijing, China. Mice were
anesthetized and inoculated intranasally with 50 μl of A/
Anhui/1/2013 (H7N9) virus. Three groups of ten mice
were separately inoculated with 108, 107, or 106 50% tis-
sue culture infectious dose (TCID50) of H7N9 virus, and
were observed daily for signs of disease and mortality up
to 14 days. The percentages of mice that survived during
the observation period were shown in Figure 1A. All of
the mice inoculated with 106 TCID50 of virus survived.
In contrast, only 80% and 40% of the mice inoculated with
107 or 108 TCID50 of virus survived on 14 d.p.i. For mice
inoculated with 106 TCID50 of virus, the loss of body
weight was observed from 2 d.p.i. and the peak loss
reached 28.9% on 9 d.p.i., after which the mice began to
steadily regain their body weight over the remaining ob-
servation period (Figure 1B and Table 1). Meanwhile, ruf-
fled fur appeared from 3 d.p.i. and the occurrence rateThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Survival percentages and weight loss changes of inoculated BALB/c mice or ferrets with H7N9 virus. (A) Three groups of ten
mice were separately inoculated with 108, 107, or 106 TCID50 of H7N9 virus, and the percentages of mice that survived during the observation
period were compared. (B) The body weight loss of mice inoculated with 106 TCID50 of virus. (C) Body temperature change of ferrets which were
inoculated with either 108 or 106 TCID50 of virus. (D) Body weight loss of ferrets which were inoculated with either 10
8 or 106 TCID50 of virus.
Data are presented as mean value ± SD.
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Table 1). Furthermore, thirty mice were also inoculated
with 106 TCID50 of H7N9 virus, and six were selected ran-
domly and euthanized on 1, 2, 3, 5, 7 d.p.i. respectively for
virus dissemination and pathology analysis. From 3 to 7 d.
p.i., gross examination of the lungs revealed focal to multi-
focal consolidation in all inoculated mice (Figure 2A (ii)).
However, gross examination of the heart, liver, spleen, kid-
ney and brain did not reveal lesions in inoculated mice.
The virus dissemination in the bronchoalveolar lavage
fluid (BALF), lung, and other main tissues (heart, liver,
spleen, kidney, intestine, and brain) of inoculated mice
were titrated on MDCK cell. Virus shedding was observed
to start on 1 d.p.i. and continued until 7 d.p.i. in both BALF
and lungs, with lung tissues containing higher virus titers
than BALF from 2 d.p.i. (P<0.05). The peak virus shedding
reached 103.75 TCID50 for BALF on 1 d.p.i. and 10
5.69
TCID50 for lung on 2 d.p.i. (Figure 3A and Table 1). Mean-
while, virus could also be isolated from the brain, liver,
spleen, kidney and intestine (Table 1). The brain tropism of
H7N9 virus was coincidence with other highly pathogenic
avian viruses such as H5N1and H7N7 [2-4].The dissemination of virus in inoculated mice were also
assessed by immunohistochemical analysis (IHC), the viral
antigens were mainly located within the epithelial cells of
the bronchial in the lung, the choroid plexus in the brain,
the villous column in the small intestine, and the renal tu-
bules in the kidney (Figure 4A (i-iv)). Meanwhile, all tis-
sues of inoculated mice were subjected to pathological
analysis. Characterization of inflammation in the lungs
revealed that from 1 d.p.i., lung tissues exhibited charac-
teristic pathology of influenza infection, including inflam-
matory hyperaemia and exudative pathological changes.
From 3 to 7 d.p.i., the lesions of lung tissue became larger,
and more severe interstitial pneumonia were observed
(Figure 4A (v-viii)).
On 14 d.p.i., sera from inoculated mice were collected
and tested for H7N9 virus specific antibodies by using HI
assay. All inoculated mice showed seroconversion, and the
HI titers ranged from 80 to 160.
It has been reported that infection with H7N9 influenza
viruses can cause leukopenia in clinical patients [1,5,6]. To
determine the extent to which infection with H7N9 virus
induced leukopenia in mice, peripheral blood leukocytes
Table 1 Clinical signs and replication of H7N9 virus in mice and ferrets
Mouse Time (d.p.i.) Clinical signs Mean virus titer (Log10 TCID50/g of tissue)
Weight loss (%)a Ruffled furb Mortality BALFc Lung Brain Heart Liver Spleen Kidney Intestine
1 3/10 0/10 0/10 (0%) 3.75 (4/6)d 4.15 (4/6) - - - - - -
2 8/10 0/10 0/10 (0%) 2.31 (5/6) 5.69 (5/6) - - - 1.25 (2/6) 1.88 (4/6) -
3 9/10 7/10 0/10 (0%) 2.75 (6/6) 4.38 (6/6) - - - - - 0.69 (5/6)
5 8/10 10/10 0/10 (0%) 3.58 (6/6) 5.38 (6/6) - - 0.58 (2/6) - - -
7 8/10 10/10 0/10 (0%) 2.31 (6/6) 3.69 (6/6) - - - - - -
Ferret Clinical signs Euthanized time (d.p.i.) Virus titer (Log10 TCID50/ tissue)
Weight Loss (%) Sneezingb Lethalityc Trachea Lung Brain Heart Liver Spleen Kidney Intestine Olfactory bulb
9/9 (10.7/9.3)e 9/9 0/9 3 4.92 (2/2)d 2.59 (2/2) - 2.82 (1/2) - - - - 5.41 (2/2)
7 4.11 (2/2) 2.87 (2/2) - - 2.16 (1/2) - - - -
a The percentage mean maximum weight loss after inoculation.
b Number of animals in which ruffled fur (mouse) or sneezing (ferret) was observed after inoculation.
c Virus titer was calculated as Log10 TCID50/ml of BALF.
d –Numbers of positive animals in total animals.
e 10.7% for animals inoculated with 108 TCID50 of H7N9 virus, and 9.3% for animals inoculated with 10
6 TCID50 of H7N9 virus.
Mice were anesthetized and inoculated intranasally with 50 μl of 106 TCID50 of A/Anhui/1/2013 (H7N9) virus and were observed daily for signs of disease and mortality up to 14 days. Meanwhile, six mice were
selected randomly and euthanized on 1, 2, 3, 5, and 7 d.p.i. respectively for virus dissemination analysis. Ferrets were divided into two groups, and three were inoculated with 108 while other six were inoculated with
106 TCID50 of A/Anhui/1/2013 (H7N9) virus. Two randomly selected animals which were inoculated with 10
6 TCID50 of virus were euthanized separately on 3 and 7 d.p.i., and used for virus replication in ferret tissues.
All nine animals were observed for clinical signs and weighed daily as an indicator of disease. Nasal and throat swabs were collected on 1, 3, 5, 7, and 9 d.p.i. and virus titers were determined by end-point titration in
MDCK cells. All data are presented as mean value ± SD.
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Figure 2 Clinical signs and gross examination of lung tissues of inoculated BALB/c mice or ferrets with H7N9 virus. (A) Clinical signs
(i) and gross examination of the lungs (ii) of inoculated mice. (B) Clinical signs (i & ii), gross examination of the lungs (iii) of inoculated ferrets.
(C) Micro-CT scanning of lungs of inoculated ferrets, the lesions were marked by ovals and arrows.
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those in the mice before inoculation, the total numbers of
white blood cells (WBCs) in the H7N9 virus inoculated
mice were reduced significantly (P<0.05) from 2 to 7 d.p.i.
Significantly reduced numbers of lymphocytes but in-
creased numbers of neutrophils (P<0.05) were also ob-
served on 2 d.p.i. in the inoculated mice (Table 2).
Ferret (Mustela putorius furo) model was also established
for H7N9 virus studies. Ferrets have been used in influenza
research since 1933 because they are susceptible to infec-
tion with human and avian influenza viruses [7]. After in-
oculation with human influenza A virus, ferrets develop
respiratory disease and lung pathology similar to that ob-
served in humans [8]. In this study, nine specific pathogen-
free castrated adult ferrets, 6 to 12 months of age that were
serologically negative by HI assay for currently circulating
influenza viruses, were randomly divided into two groups.
One group included three ferrets, which were inoculatedintranasally with 108 TCID50 of A/Anhui/1/2013 (H7N9)
virus, were used for taking chest radiographs daily. An-
other group included left six ferrets, which were inoculated
intranasally with 106 TCID50 of A/Anhui/1/2013 (H7N9)
virus. Two randomly selected animals were euthanized sep-
arately on 3 and 7 d.p.i., and used for pathological and viro-
logical examination of the trachea, lung, brain, heart, liver,
spleen, kidney, stomach, intestine, and olfactory bulb. All
nine animals were observed for clinical signs and weighed
daily as an indicator of disease. Nasal and throat swabs
were collected on 1, 3, 5, 7, 9 d.p.i. and transferred to 1 ml
of phosphate buffer solution (PBS). Virus titers were deter-
mined by end-point titration in MDCK cells.
Results showed that both doses caused fever (Figure 1C),
weight loss (Figure 1D), sneezing (Figure 2B (i)), lethargy
(Figure 2B (ii)), decreased appetite for food in ferrets. For
ferret inoculated with 108 TCID50 of virus, the mean
highest body temperature and maximum weight loss was
Figure 3 Virus shedding of inoculated BALB/c mice or ferrets with H7N9 virus. (A) Virus shedding in the BALF and lung tissues of
inoculated mice. (B) Virus shedding in the nasal and throat swabs of inoculated ferrets. Data are presented as mean value ± SD. * P<0.05.
Figure 4 Histopathological analyses of tissues of inoculated mice and ferrets. (A) Hematoxylin and Eosin (H-E) stain and immunohistochemical
(IHC) analyses of tissues of inoculated mice. (B) Hematoxylin and Eosin (H-E) stain and IHC analyses of lungs of inoculated ferrets.
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Table 2 Impact of viral infection on the mouse and ferret
lymphocyte populations in whole blood
Animal Time (d.p.i.) WBCa % LYb % NEb
Mouse −1c 12.0 78.4 12.5
1 11.4 64.4 23.3
2 6.9* 48.7* 43.8*
3 5.5* 62.5 27.1
5 6.8* 77.1 15.7
7 5.3* 64.6 21.5
Ferret −1 15.9 64.8 17.9
7 8.4* 38.8* 57.6*
14 13.4 55.1 37.7*
a Number of white blood cells (WBC) in whole blood, expresses as thousands
of WBCs per microliter of whole blood.
b Mean percentage of leukocytes that are lymphocytes (LY) or neutrophils (NE)
from 6 mice per group.
c -1 d.p.i.: the day before inoculation.
* Statistical significance: * P<0.05 compared to the values of −1 d.p.i..
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inoculated with 106 TCID50 of virus, the corresponding
data were 40.1°C on 4 d.p.i. and 9.3% on 5 d.p.i. through-
out the course of 14 days (Figure 1C&D). Gross examin-
ation of the lungs revealed multifocal consolidation in all
ferrets which were inoculated with 106 TCID50 of H7N9
virus and euthanized separately on 3 and 7 d.p.i. (Figure 2B
(iii)). However, gross examination of the brain, heart, liver,
spleen, kidney, stomach, intestine, and olfactory bulb did
not reveal lesions in inoculated ferrets.
Histopathological analyses revealed that on 3 d.p.i.,
lung tissue had a multifocal mild or moderate intersti-
tial inflammatory hyperaemia and exudative pathological
changes, while on 7 d.p.i., the lesions of lung tissue be-
came larger, and fusing of multiple patchy lesions were
observed (Figure 4B (iii-iv)). Immunohistochemistry was
also performed to assess the presence of H7N9 influenza
virus infected cells in tissues including bronchial epithe-
lial cells and alveolar epithelial cells from infected ferrets
(Figure 4B (i-ii)).
For ferrets inoculated with 108 TCID50 of H7N9 virus,
chest radiograph was taken by micro-CT scanning. Re-
sults showed that there were inflammatory lesions (mild
to bilateral ground-glass opacity) in the right superior
lobe from 6 d.p.i. to 14 d.p.i. (Figure 2C).
Nasal and throat swabs were collected from inoculated
animals on 1, 3, 5, 7, 9 d.p.i., and virus shedding was ob-
served to start on 1 d.p.i. for both doses, and continued
until 7 d.p.i.. The peak virus shedding in ferrets inoculated
with 108 TCID50 of virus reached 10
4.38 TCID50/ml on 3
d.p.i. from throat swab, while for ferrets inoculated with
106 TCID50 of virus, the peak shedding reached 10
4.11
TCID50/ml on 5 d.p.i. from nasal swab (Figure 3B).
Parts of the tissues from euthanized ferrets were ho-
mogenized and virus titers were determined. For animalseuthanized on 3 d.p.i., virus could be detected in the lung
(102.59 TCID50/gram), trachea (10
4.92 TCID50/gram), and
olfactory bulb (105.41 TCID50/gram) of both ferrets, and
heart (102.82 TCID50/gram) of one ferret. On 7 d.p.i., the
H7N9 virus could be isolated from the trachea (104.11
TCID50/gram) and lung (10
2.87 TCID50/gram) of both fer-
rets, and liver (102.16 TCID50/gram) of one ferret (Table 1).
On 14 d.p.i. sera from inoculated ferrets were collected
and tested for H7N9 virus specific antibodies by using
HI assay. All inoculated ferrets showed seroconversion,
and the HI titers ranged from 160 to 1280.
Meanwhile, leukopenia, significantly reduced numbers
of lymphocytes but increased numbers of neutrophils
(P<0.05) were also observed on 7 d.p.i. in the inoculated
ferrets (Table 2).
Collectively, H7N9 virus caused typical clinical symp-
toms in both BALB/c mice and ferrets, and virus shed-
ding or replication could also be detected in respiratory
tract and other tissues, which was generally coincidence
with recent other reports [9-12]. However, Mok et al.
did not detected H7N9 virus dissemination beyond the
respiratory tract of mice which were inoculated with 105
PFU of A/Shanghai/2/2013 virus [12]. The discrepancy of
virus distribution results between us may be caused by the
different choices in inoculated virus and dosage. Mean-
while, Belser et al. found that systemic spread of virus to
liver and heart could not been detected in inoculated fer-
rets [9]. We supposed that the different species of ferrets
used for studies may be the main cause of discrepant re-
sults between us. These animal models establish the causal
relationship between H7N9 virus and respiratory disease in
both mouse and ferret reminiscent of the respiratory dis-
ease observed in humans, thus fulfilling Koch’s postulates.
The mouse and ferret models enables detailed studies of
the pathogenesis of this illness and lay the foundation for
drug or vaccine evaluation.Materials and methods
Viruses
Influenza virus A/Anhui/1/2013 (H7N9) was isolated from
the third case of laboratory-confirmed human A (H7N9)
virus, with Q226L mutation in the receptor binding do-
main of HA protein. The patient was a 35-year-old woman
who lived in Anhui Province of China. She had visited a
chicken market one week before the onset of symptoms.
ARDS, septic shock, and acute renal damage developed on
day 6 post the onset of illness. The patient was treated
with oseltamivir (started on day 8), but eventually died on
19 days after the onset of illness [1]. A throat swab was
collected from the patient and propagated in the allantoic
sac and amniotic cavity of 9-to-11-day old embryonated
chicken eggs, then passaged once in Madin-Darby canine
kidney (MDCK) cells.
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MDCK cells were maintained in Eagle’s minimal essen-
tial medium (MEM, Invitrogen) in all instances supple-
mented with 10% fetal bovine serum (FBS), 100 IU/ml
penicillin, 100 μg/ml of streptomycin and cultured at 37°C
with 5% CO2.
Animal models
Mouse
Female 6-week-old specific pathogen-free BALB/c mice
used in this study were obtained from the Institute of
Laboratory Animal Sciences, Beijing, China. Mice were
anesthetized and inoculated intranasally with 50 μl of
A/Anhui/1/2013 (H7N9) virus. Three groups of ten mice
were separately inoculated with 108, 107, or 106 50% tis-
sue culture infectious dose (TCID50) of H7N9 virus, and
were observed daily for signs of disease and mortality up
to 14 days. The status of weight loss was evaluated by
monitoring the rate of weight change, which is calcu-
lated as follows: [(value at day of monitoring - value at 0
days post inoculation (d.p.i.))/value at 0 d.p.i.] ×100%.
Ruffled fur was recorded daily and used as the standard
of clinical changes, and the morbidity rate was calculated
as the number of mice exhibiting ruffled fur against the
monitored animals. Meanwhile, thirty mice were also in-
oculated with 106 TCID50 of H7N9 virus, and six were
selected randomly and euthanized on 1, 2, 3, 5, and 7 d.p.i.
respectively for virus dissemination and pathology analysis.
Ferret
Nine specific pathogen-free castrate adult ferret (Mustela
putorius furo), 6 to 12 months of age that were serologic-
ally negative by haemagglutinin inhibition (HI) assay for
currently circulating influenza viruses, were randomly di-
vided into two groups. One group included three ferrets,
which were inoculated intranasally with 400 μl of 108
TCID50 of A/Anhui/1/2013 (H7N9) virus, were used for
taking chest radiographs daily. Another group included
left six ferrets, which were inoculated intranasally with
400 μl of 106 TCID50 of A/Anhui/1/2013 (H7N9) virus.
Two randomly selected animals were euthanized sepa-
rately on 3 and 7 d.p.i., and used for pathological and viro-
logical examination of the trachea, lung, brain, heart, liver,
spleen, kidney, stomach, intestine, and olfactory bulb. All
nine animals were observed for clinical signs and weighed
daily as an indicator of disease. Nasal and throat swabs
were collected on 1, 3, 5, 7, 9 d.p.i. and transferred to 1 ml
of phosphate buffer solution (PBS). Virus titers were de-
termined by end-point titration in MDCK cells.
The experimental protocol was evaluated and approved
by the Institute of Animal Use and Care Committee of the
Institute of Laboratory Animal Science, Peking Union Med-
ical College (ILAS-PC-2013-009). All experiments were
performed under ABSL-3 conditions.Virus titrations
Virus titrations were performed by end-point titration in
MDCK cells. MDCK cells were inoculated with tenfold
serial dilutions of homogenized tissues, nasal and throat
swabs in 96-well plates. One hour after inoculation, cells
were washed once with PBS and grown in 200 μl of in-
fection media, consisting of MEM supplemented with
100 IU/ml penicillin, 100 μg/ml streptomycin, and 1 μg/ml
TPCK-trypsin. At 3 d.p.i., the supernatants of infected cell
cultures were tested for agglutinating activity using turkey
erythrocytes as an indicator of infection of the cells. In-
fectious titers were calculated from five replicates by the
method of Reed and Muench [13].
Histopathology and immunohistochemistry
Animal necropsies were performed according to a stand-
ard protocol. Samples for histological examination were
stored in 10% neutral-buffered formalin (lungs after in-
flation with formalin), embedded in paraffin, sectioned at
4 μm, and stained with hematoxylin and eosin (H&E) for
examination by light microscopy or with an immunohis-
tochemical method using a monoclonal antibody against
the nucleoprotein of influenza A virus (1:200 dilution, IRR
Ltd, Catalogue No: FR-51) at 4°C overnight. The sections
were washed three times with PBS and then incubated
with HRP-conjugated goat anti-mouse secondary antibody
(1:5000 dilution, Sigma, Catalogue No: PV-9002). The sec-
tions were developed with 3-3’ diaminobenzidine (DAB)
and examined with a light microscope.
Hematology analysis
The total white blood cell (WBC) counts and lymphocytes
in individual heparinized blood samples were determined
on an ACT TM laser-based hematology analyzer (Beckman
Coulter, USA).
Micro-CT scanning
Scans were performed using a cone-beam micro-CT scan-
ner (Inveon, Siemens Healthcare, Germany). Inoculated fer-
rets were anesthetized and placed prone position on the
micro-CT bed without respiratory gating. The tube voltage
was 70 kVp and current was 400 mA, and exposure time
was 800 ms. The scan field of view (FOV) was 72.44 mm ×
71.31 mm. Projections images were acquired using a single
tube/detector over a circular orbit of 360° with a step angle
of 1°. Reconstructions were performed using a commer-
cially available CT reconstruction program (COBRA Exxim,
v6.3), with a filtered back projection technique. A resolution
of approximately 70.74 μ/pixel was achieved.
HI assays
Standard HI assays were performed on post-exposure fer-
ret sera using 0.5% turkey erythrocytes in accordance with
WHO guidelines with established procedures [14]. Sera
Xu et al. Virology Journal 2013, 10:253 Page 8 of 8
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H7N9 virus specific antibodies.Statistical analysis
The difference in ferret body weight and virus titers among
different groups was analyzed by one-way ANOVA and
post hoc. Bonferroni correction analysis and the difference
between two groups were analyzed by Student’s t-test
using SPSS 11.5 software. A probability value of <0.05 was
considered as statistically significant.
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